DIVA Laboratories, Ltd. (TPEX:4153)

Taiwan · Delayed Price · Currency is TWD

30.90

-0.75 (-2.37%)

Oct 8, 2026, 1:30 PM CST

Market Cap	1.81B -19.8%
Revenue (ttm)	894.67M +4.2%
Net Income	95.99M +7.9%
EPS	1.63 +7.9%
Shares Out	58.67M
PE Ratio	18.96
Forward PE	n/a
Dividend	2.00 (6.47%)
Ex-Dividend Date	Jun 12, 2026

Volume	27,595
Open	31.80
Previous Close	31.65
Day's Range	30.90 - 31.80
52-Week Range	29.00 - 38.80
Beta	0.25
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 27, 2026

About DIVA Laboratories

DIVA Laboratories, Ltd. engages in the research, development, manufacture, and sale of medical devices and computer peripherals worldwide. The company provides endo/surgical displays for hybrid and other types of OR applications; color and mono displays for radiology applications; and touch and embedded display, as well as industrial displays. DIVA Laboratories, Ltd. was founded in 1984 and is headquartered in New Taipei City, Taiwan. [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1984

Employees 154

Stock Exchange Taipei Exchange

Ticker Symbol 4153

Full Company Profile

Financial Performance

In 2025, DIVA Laboratories's revenue was 868.84 million, an increase of 0.76% compared to the previous year's 862.32 million. Earnings were 90.54 million, a decrease of -3.33%.

Financial Statements